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Background/aim: Primary hyperparathyroidism (PHPT) is an endocrine disorder characterized by hypercalcemia caused by excessive
parathyroid hormone (PTH) secretion from the parathyroid gland. PHPT was previously shown to increase cardiac arrhythmias.
Besides, new indices, such as the Tpeak-Tend (Tp-e) interval, Tp-e interval/QT interval (Tp-e/QT) ratio, and Tp-e interval/corrected QT
interval (Tp-e/QTc) ratio may be associated with ventricular arrhythmias and sudden cardiac death. Therefore, we aimed to investigate
the relationship between PHPT and the changes to Tp-e interval, Tp-e/QT ratio, and Tp-e/QTc ratio.
Materials and methods: We carried out the study with 41 patients with PHPT and 40 control subjects. We calculated the Tp-e interval,
Tp-e/QT ratio, and Tp-e/QTc ratio of the participants from the V5 derivations on their ECG papers. While we defined Tp-e interval as
the distance between the peak and the end of the T wave, Tp-e/QT and Tp-e/QTc ratios were calculated by dividing Tp-e by QT and
Tp-e by QTc, respectively.
Results: Total calcium, albumin-corrected calcium, phosphorus, and PTH levels were significantly higher in patients with PHPT. We
also found positive correlations between albumin-corrected calcium and PTH levels and Tp-e interval, Tp-e/QT ratio, and Tp-e/QTc
ratio (p < 0.001).
Conclusion: Our results suggest that Tp-e may enhance the current knowledge on arrhythmic risk in PHPT patients better than basal
ECG. In addition, both high PTH and high calcium levels appear to have the potential to cause arrhythmogenic effects.
Key words: Primary hyperparathyroidism, Tp-e interval, cardiac arrhythmia, electrocardiogram

1. Introduction
Primary hyperparathyroidism (PHPT) is an endocrine
disorder characterized by hypercalcemia caused by
excessive parathyroid hormone (PTH) secretion from
the parathyroid gland and the most common cause of
hypercalcemia in outpatient clinics [1–3]. It has been
observed more frequently in the last 40 years due to
widespread measurements of serum calcium levels [4].
Consequently, PHPT has been becoming a relatively more
common endocrine disease with an incidence of 1/1000
[5]. Recently, there has been an increasing interest in
cardiac evaluation for patients with PHPT, which may
stem from the previous findings that PHPT may increase
cardiac mortality and arrhythmias [6,7].
Ventricular recovery and repolarization dispersion
on electrocardiogram (ECG) are valuable markers for
probable ventricular arrhythmias [8]. The literature
hosts several studies suggesting specific ventricular

repolarization markers, such as the QT interval and T
wave alternans, to be helpful in predicting the arrhythmias
[9,10]. Besides, recent studies revealed that novel indices,
such as the Tpeak-Tend (Tp-e) interval, Tp-e interval/
QT interval (Tp-e/QT) ratio, and Tp-e interval/corrected
QT interval (Tp-e/QTc) ratio may be associated with
ventricular arrhythmias and sudden cardiac death in
various disease groups [11,12].
Ultimately, in this study, we aimed to investigate the
relationship between PHPT and the changes to novel
arrhythmia markers in PHPT patients: Tp-e interval, Tp-e/
QT ratio, and Tp-e/QTc ratio.
2. Methods
2.1. Sample and research protocol
We recruited and prospectively analyzed 41 randomized
patients followed up with a diagnosis of PHPT in Kayseri
City Hospital in September 2020. The control group, on
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the other hand, consisted of 40 randomized, age-gender
matching subjects with normal blood PTH levels, who
were not suspected of having coronary artery disease based
on their medical history, physical examination findings,
and ECG and echocardiography results. We recorded
the physical examination findings, medical history, and
laboratory results of all the participants.
We deemed the exclusion criteria as follows:
uninterpretable ECGs (the ones with left bundle branch
block, presence of a cardiac pacemaker, and U-waves and
negative T-waves in prewarning ECGs), hypertrophic
cardiomyopathy, severe valvular disease, coronary
artery disease, hypothyroidism and hyperthyroidism,
hypokalemia and hyperkalemia, hypomagnesemia and
hypermagnesemia, creatinine clearance (CrCl) <60 ml/
min, and Body Mass Index (BMI) >30 kg/m2. None of
our patients were using any medication affecting the QT
interval. We obtained written informed consent from
all patients, as well as approval from the local ethics
committee.
2.2. Electrocardiogram analysis
We took all standard 12-lead ECGs in the supine
position and at rest using an ECG device (Philips brand)
standardized to 1 mV/cm and 25 mm/s paper speed.
Then, we scanned and transferred all ECGs into a digital
environment. Next, we digitally enlarged ECGs five times
for measurement convenience and took the measurements
using an electronic caliper (Cardio Calipers software
version 3.3; Iconico.com, Philadelphia, PA, USA). Two
experienced cardiologists blinded to the clinical data
carried out ECG evaluations.
We defined the Tp-e interval as the distance between
the peak and the end of the T wave. All Tp-e intervals were
measured using the best T wave, if available, and lead V5
in general [13]. Yet, we had to use lead V4 or V6 when lead
V5 was not suitable for the analysis.
On the other hand, we adopted the QT interval as the
distance from the beginning of the QRS complex to the end
of the T wave. It was measured in lead V6, reflecting the
transmural axis of the left ventricle the best, and corrected
based on the heart rate using Bazett’s formula, that is QTc
= QT/√R-R (R-R interval). Finally, we computed Tp-e/
QT and Tp-e/QTc ratios by dividing Tp-e by QT and Tp-e
by QTc, respectively. The intraobserver and interobserver
coefficients of variation were below 5%.
2.3. Echocardiography measurements
We
performed
conventional
echocardiographic
examinations on the subjects utilizing an M4S-RS (1.53.6 MHz) cardiac transducer and a Vingmed System 5
(General Electronic Horten, Norway) echocardiography
device. We measured left ventricular diastolic (LVIDd)
and systolic (LVIDs) diameters, interventricular septum
(IVSWT), and posterior wall (LVPWT) diastolic
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thicknesses on the parasternal long axis with M-mode
echocardiography, following the standards defined by
the American Echocardiography Association. Finally,
the ejection fraction was calculated using the Teichholz
formula [14].
3. Statistical analyses
We performed all statistical analyses using the SPSS
Statistics software version 21.0 (SPSS Inc, Chicago, IL,
USA) for Windows. Initially, we checked the distribution
characteristics of the data using the Kolmogorov–
Smirnov test. Then, we ran an independent samples
t-test for parametric variables. We utilized a chi-square
test for univariate analysis of the categorical variables.
The variables were reported as means (M) ± standard
deviations (SD), whereas the categorical variables were
presented as percentages. Finally, we performed relevant
correlation analyses (Pearson and Spearman-Brown)
to reveal the associations between albumin-corrected
calcium and PTH levels and Tp-e interval, Tp-e/QT ratio,
and Tp-e/QTc ratio, respectively. In all statistical analyses,
we considered a probability value of p <0.05 as significant.
4. Results
Table 1 presents the initial clinical and demographic
characteristics of the sample. Accordingly, there were no
significant differences between the patient and control
groups by sex, age, smoking, diabetes, and hypertension
(p > 0.05).
Table 1. Baseline clinical
characteristics of the sample.

findings

and

demographic

Variables

Control group
(n = 40)

PHPT
(n = 41)

p value

Age (years)

57.52 ± 11,10

57.53 ± 12,35

.9961

Male/female

37/3

37/4

.7181

HT

19 (47.5%)

19 (46.3)

.9172

DM

7 (17.5 %)

7 (17.1%)

.9592

Smoke

1 (2%)

1 (2%)

.9862

SBP (mm/hg)

119.50 ± 10.20

122.60 ± 11.50 .2011

DBP (mm/hg)

73.70 ± 7.20

74.70 ± 6.30

.5071

BMI

57.52 ± 11.10

57.53 ± 12.35

.6801

PHPT; Primary hyperparathyroidism, DM: Diabetes Mellitus,
HT: Hypertension, SBP: Sistolic Blood Pressure, DBP: Diastolıc
Blood Pressure, BMI; Body Mass Index, Data are expressed as
mean ± standard deviation for normally distributed data and
percentage (%) for categorical variables.
P1: Independent samples t-test.
P2: Chi-square.
Statistically significant (p < 0.05).
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The baseline laboratory findings of the subjects are
listed in Table 2. Accordingly, total calcium, albumincorrected calcium, phosphorus, and PTH levels were
significantly higher in PHPT patients than healthy controls
(p < 0.01 for all). Yet, the groups yielded similar results
in other blood parameters. Moreover, the groups did not
differ significantly in their echocardiographic parameters
(Table 3).
ECG parameters of the groups are shown in Table
4. Heart rate and QRS duration were similar between
the patient and control groups (p = 0.344 and p = 0.220,
respectively). Yet, the QT interval was shorter in the
patient group than in the control group, contrary to the
QTc interval, which was similar between the groups (p =
0.006 and p = 0.810, respectively). Finally, we concluded
that Tp-e interval, Tp-e/QT ratio, and Tp-e/QTc ratio were
significantly higher in PHPT patients compared to the
control group (p < 0.01 in all) (Figure 1).
The correlation analysis revealed positive significant
associations between albumin-corrected calcium levels
and Tp-e interval, Tp-e/QT ratio, and Tp-e/QTc ratio (r =
0592, p <0.001; r = 0.560, p <0.001; r = 0.564, p <0.001,
respectively) (Figure 2). There were also positive significant
relationships between PTH levels and Tp-e interval, Tp-e/
QT ratio, and Tp-e/QTc ratio (r = 457, p <0.001; r = 0.449,
p <0.001; r = 0.409, p <0.001, respectively) (Figure 3).
5. Discussion
This is the first randomized study in which we demonstrated
the prolongation of ECG-detected Tp-e interval to be

higher in PHPT patients compared to the healthy subjects.
It is well-known that PHPT is associated with
hypertension,
cardiac
arrhythmias,
endothelial
dysfunction, glucose metabolism disorder, and metabolic
syndrome. Previous research uncovered that both
PTH and calcium levels affect cardiomyocytes, the
heart conduction system, and smooth vascular and
endothelial cells. Excessive secretion of PTH can affect the
myocardium and alter repolarization. Although the effects
of PTH on the heart were previously thought to be due
to hypercalcemia, it is now known that PTH itself causes
hypertrophy in cardiac myocytes and vascular smooth
muscles independent of calcium levels. In addition, it was
reported in the literature that there is a direct link between
endothelial dysfunction and PTH [15–19].
Hypercalcemia,
including
PHPT-induced
hypercalcemia, is a risk factor for cardiac arrhythmias
[20,21]. Hypercalcemia, which develops in primary
hyperparathyroidism, is conventionally accepted to cause
shortening of the QT interval, a decrease in the ST segment,
and a slight prolongation in the PR and QRS intervals
[22]. The shortening of the refractory period due to QT
shortening may lead to complex ventricular arrhythmias
or sudden deaths [22].
So far, three different cell types have been identified in
the ventricle electrophysiologically, namely endocardial,
epicardial, and myocardial M cells [23,24]. The peak of the
T wave indicates epicardial repolarization, whereas the end
of the T wave is shown to overlap with the repolarization
of M cells. Hence, the Tp-e interval is the duration of

Table 2. Comparison of baseline laboratory measurements of the sample.
Variables

Control Group
(N = 40)

PHPT
(N = 41)

p value

Glucose (mg/dL)

94.6 ± 10.90

97.8 ± 13.50

.237

Creatinin (mg/dL)

0.84 ± 0.19

0.83 ± 0.15

.730

AST (U/L)

19.8 ± 6.30

19.6 ± 6.80

.920

ALT (U/L)

19.05 ± 6.80

20.95 ± 10.4

.355

Albumin

3.96 ± 0,50

4.53 ± 0.30

.001

Total calcium (mg/dL)

9.53 ± 0.36

11,29 ± 0.73

.001

Albumin-corrected calcium (mg/dL)

9.13 ± 0.44

10.87 ± 0.69

.001

Phosphorus (mg/dL)

3.72 ± 0.41

2.57 ± 0.50

.001

PTH

35.20 ± 8.16

226.91 ± 172.51

.001

D Vitamin

20.11 ± 7.7

19.66 ± 7.98

.800

Platelet (x103/mm3)

264.2 ± 68.0

259.2 ± 62.60

.729

PHPT: Primary hyperparathyroidism, PTH: Parathyroid Hormone. Data are expressed as mean ±
standard deviation for normally distributed data and percentage (%) for categorical variables.
p value: independent samples t-test.
*Statistically significant (p < 0.05).
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Table 3. Echocardiographic characteristics of the sample.

Table 4. Electrocardiographic characteristics of the sample.

Variables

Control Group
(N = 40)

PHPT
(N = 41)

p value

Variables

Control Group PHPT
(N = 40)
(N = 41)

LVEDD

4.68 ± 0.41

4.80 ± 0.44

.198

Heart rate (beat/min) 75.9 ± 8.5

78.1 ± 12.07 .344

LVESD

3.11 ± 0.41

3.05 ± 0.32

.463

QRS duration (ms)

85.0 ± 8.5

82.6 ± 8.6

IVSD

1.05 ± 0.97

1.05 ± 0.18

.871

QT interval (ms)

380.3 ± 20.7

365.2 ± 27.4 .006*

PWD

1.01 ± 0.84

1.01 ± 0.17

.915

QTc interval (ms)

421.2 ± 15.4

412.8 ± 25.9 .081

LVEF

62.3 ± 3.1

63.3 ± 4.1

.214

Tp-e (ms)

79.5 ± 5.2

94.09 ± 5.7

.001*

TPe/QTc ratio (ms)

0.18 ± 0.01

0.22 ± 0.02

.001*

TPe/QT ratio (ms)

0.20 ± 0.15

0.25 ± 0.23

.001*

p value

.220

PHPT; Primary hyperparathyroidism, LVEDD: Left Ventricular
End Diastole Diameter, LVESD: Left Ventricular End Systole
Diameter, IVSD: İnterventricular Septal Diameter, PWD:
Posterior Wall Diameter, LVEF; Left Ventricular Ejection
Fraction, Data are presented as mean ± standard deviation for
normally distributed data and percentage (%) for categorical
variables.
p value: independent samples t-test.
Statistically significant (p < 0.05).

PHPT; Primary hyperparathyroidism. Data are shown as mean ±
standard deviation for normally distributed data and percentage
(%) for categorical variables. Tp-e= T wave interval from peak to
end, c = corrected,
P value: independent samples t-test.
*Statistically significant (p < 0.05).

the transmural distribution of repolarization [25]. In the
literature, Tp-e was shown to be related to life-threatening
arrhythmic events, referring to that Tp-e helps predict the
risk of developing arrhythmias [12,26–30]. However, QT
and Tp-e intervals widely vary among individuals, and the
Tp-e interval is affected by the changes in the heart rate.
For this reason, the Tp-e/QT ratio is considered to be
more consistent among individuals and their heart rates,
regardless of their Tp-e interval values [8].
Pepe et al. and Curione et al. demonstrated that the
mean QTc values of the patients with PHPT lie within
the normal range but were significantly lower than the
mean QTc values of the control group [31,32]. Curione
et al. found QT intervals to be shorter in their patients
with PHPT; however, the difference was not statistically
significant. They also concluded QT intervals to be within
the normal range [33]. In our study, we also found that
QT intervals were shorter in the patient group than in the
control group. In addition, similar to the findings of the
studies above, we could not find any significant differences
between QTc intervals of the patient and the control
groups; they were within normal limits, as well. Such
a finding may be due to the mild hypercalcemia in our
patients since PHPT patients with higher calcemic levels
are known to have shorter QT intervals.
Our findings showed that Tp-e interval, Tp-e/QT ratio,
and Tp-e/QTc ratio were higher in patients compared to
the control group. Yamaguchi et al. suggested that the
Tp-e/QT ratio is a better predictor of torsade de pointes
than the QTc interval [25]. Watanabe et al. demonstrated
that longer Tp-e intervals are associated with spontaneous
ventricular tachycardia. Besides, Shimizu et al. reported

that Tp-e/QT ratios were higher in patients developing
sudden cardiac death than those who did not [29, 34].
Hevia et al. revealed that the incidence of recurrent cardiac
events is significantly higher in patients with increased
Tp-e ranges [12]. Ventricular arrhythmias in PHPTwere
generally reported in the form of case reports in the
literature; however, we could not encounter follow-up
studies of the long-term cardiovascular consequences of
PHPT. Nilsson et al. and Pepe et al. reported an increase
in ventricular extrasystolic beats (VPB) in patients with
PHPT [31,35]. They demonstrated the predictor of VPBs
in PHPT patients to be serum total calcium levels [31].
In our follow-up study, we concluded our patients to
have increased Tp-e interval, Tp-e / QT ratio, and Tp-e
/ QTc ratio, which are considered strong predictors of
cardiac arrhythmia. Along with the results reported in
the literature, our results suggest that patients with PHPT
are at risk for severe ventricular arrhythmia and sudden
cardiac death.
On the other hand, we found correlations between
Tp-e interval, Tp-e/QT ratio, Tp-e/QTc ratio, and total
calcium levels and PTH levels in the patients. Curione et
al. demonstrated that the QT interval remained unchanged
even though serum calcium levels improved following
parathyroidectomy [32]. The correlation between PTH
and Tp-e interval, Tp-e/QT ratio, and Tp-e/QTc ratio in
our study suggest that arrhythmogenesis mechanisms may
be associated with both PTH and calcium levels. PTH
has chronotropic effects on animal models and affects
coronary blood flow and contraction [36]. PTH may cause
both hypertrophy and necrosis by directly affecting the
cardiac myocytes, and hypercalcemia may also affect Tp-e
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Figure 1: Change of Tp-e interval, Tp-e/QT ratio and Tp-e/QTc ratio between study groups
0,35

A

0,30

Tp-e (msn)

Tp-e/QT

100,00

Tp-e (msn)

B

90,00

80,00

0,25

0,20

r=0.592
p<0.001

70,00

Tp-e/QTc

110,00

r=0.564
p<0.001

0,15
8,00

9,00

10,00

11,00

12,00

13,00

8,00

9,00

Albumin-corrected calcium
0,30

10,00

11,00

12,00

13,00

Albumin-corrected calcium

C

Tp-e/QT

Tp-e/QTc

0,27

0,24

0,21

r=0.560
p<0.001

0,18
8,00

9,00

10,00

11,00

12,00

13,00

Albumin-corrected calcium

Figure 2. (A) Correlation between Tp-e interval and albumin-corrected calcium count. (B) Correlation between Tp–e/QTc ratio and
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between
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ratio and albuminalbumin-corrected
calcium
count.
(C)interval
Correlation
between Tp–e/QT
ratio
and(B)
albumin-corrected
calcium
count
corrected calcium count. (C) Correlation between Tp–e/QT ratio and albumin-corrected calcium count

and QT durations by electrically shortening the plateau
phase of the cardiac action potential and the effective
refractory period [37–39]. In addition, PTH has been

shown to increase systemic inflammation markers [40].
Inflammation markers may also have affected Tp-e and
QT by affecting cardiac repolarization. Our results indicate
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that arrhythmogenesis mechanisms may be associated
with both PTH and calcium levels.
To date, the research with PHPT patients has
investigated the risk of cardiac arrhythmia through the
QT interval. It is not veiled that shortening the duration
of the QT interval is associated with an increased risk of
arrhythmia and sudden cardiac death. It is a matter of
debate whether the risk of arrhythmia increases in PHPT
patients with a regular QT interval. In this study, we
demonstrated that ventricular repolarization showed an
abnormal distribution with an increase in Tp-e interval,
Tp-e/QT ratio, and Tp-e/QTc ratio in PHPT patients with
normal QT interval regardless of the QT interval and
that this group of patients is more susceptible to future
ventricular arrhythmias and sudden cardiac death.
The present research bears few limitations. First, we
had no information on how long the patients had lived
with PHPT and hypercalcemia before the diagnosis.
Second, we did not know the threshold values of PTH or
calcium levels, which may lead to significant changes in the
heart, as well as the duration for how long PTH or calcium
levels must remain high for these significant changes to
occur. Most of the studies to that effect included patients
with symptomatic diseases. Therefore, an intervention in a
presymptomatic stage and a lower level of hypercalcemia
may perhaps alter the disease trajectory. Finally, although
values such as Tp-e interval, Tp-e/QT ratio, and Tp-e/QTc
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ratio are secondary markers of arrhythmia, we did not
perform long-term clinical follow-ups and rhythm Holter
follow-ups to detect the development of arrhythmia.
6. Conclusion
Our results suggest that Tp-e may provide more information
about arrhythmic risk in PHPT patients than basal ECG.
In addition, both higher PTH and calcium levels appear
to have the potential to cause arrhythmogenic effects. A
larger sample and long-term follow-up studies are needed
to observe the clinical consequences of these findings
and, perhaps, to come to a decision of an earlier medical
treatment or surgery.
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